Page last updated: 2024-10-22

ag-1296 and Kidney Neoplasms

ag-1296 has been researched along with Kidney Neoplasms in 2 studies

6,7-dimethoxy-3-phenylquinoxaline: ATP-competitive inhibitor of receptor kinase

Kidney Neoplasms: Tumors or cancers of the KIDNEY.

Research Excerpts

ExcerptRelevanceReference
"The authors studied the effect of genistein (broad-spectrum GFR-TK inhibitor), AG1478 (EGFR-specific GFR-TK inhibitor), and AG1295 (PDGFR-specific GFR-TK inhibitor) on proliferation and colonigenic growth of rhabdoid tumor of the kidney and Wilms' tumor cell lines: G-401 and SK-NEP-1, respectively."3.70Receptor tyrosine kinase inhibition suppresses growth of pediatric renal tumor cells in vitro. ( DeMattia, JA; Khoshyomn, S; Naraghi, S; Vane, DW, 2000)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Naraghi, S1
Khoshyomn, S1
DeMattia, JA1
Vane, DW1
de Paulsen, N1
Brychzy, A1
Fournier, MC1
Klausner, RD1
Gnarra, JR1
Pause, A1
Lee, S1

Other Studies

2 other studies available for ag-1296 and Kidney Neoplasms

ArticleYear
Receptor tyrosine kinase inhibition suppresses growth of pediatric renal tumor cells in vitro.
    Journal of pediatric surgery, 2000, Volume: 35, Issue:6

    Topics: Adult; Cell Division; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Female; Genistein; Humans

2000
Role of transforming growth factor-alpha in von Hippel--Lindau (VHL)(-/-) clear cell renal carcinoma cell proliferation: a possible mechanism coupling VHL tumor suppressor inactivation and tumorigenesis.
    Proceedings of the National Academy of Sciences of the United States of America, 2001, Feb-13, Volume: 98, Issue:4

    Topics: Adenocarcinoma, Clear Cell; Cell Division; Cell Hypoxia; Enzyme Inhibitors; ErbB Receptors; Gene Exp

2001